antigens, as with sarcomas and melanomas,' acute leukaemias,5 and Burkitt's lymphoma (Drs Magrath and Ziegler), often retain good immune reactivity to common antigens; thus the general immune status often fails to correlate with the host-tumour relationship. We assume that in these cases suppressor cells specifically inhibit tumour rejection mechanisms. For the demonstration of this activity suppression of lymphocyte blastogenesis to autologous tumour cells by a clone of lymphoid cells added to the mixture of reactor and tumour cells would be necessary.
This oversimplified view is in need of experimental support, but the basic techniques for the detection of human suppressor cells are already available.' 2 Means of deactivating suppressor cells could develop into an innovative modality of tumour immunotherapy, whereas activation of suppressor cells (by administration of fetal antigens?) may be useful for organ transplant acceptance. The hormonal milieu of the immediate post-partum period, selective immunosuppression during tumour chemotherapy,6 and ablative procedures (splenectomy, lymphadenectomy, adult thymectomy) come to mind as possible procedures of deactivation and elimination of suppressor cells.
Co-trimoxazole and cephalexin in urinary tract infection SIR,-A plausible explanation is to hand for the superior performance of co-trimoxazole compared with cephalexin in the urinary tract infection trial of Drs P E Gower and P R W Tasker (20 March, p 684).
Contrary to their statement that "cephalexin readily induces spheroplast formation," it has repeatedly been shown '-4 Diseases, 1973, 128, 211. 5Greenwood, D, and O'Gradv, F, Journal of Infectious Diseases, 1975, 132, 233. 'Greenwood, D, Teoh, C H C, and O'Grady, F, Antimicrobial Agents and Chemotherapy, 1975, 7, 693. 7 Greenwood, D, and O'Grady, F, Journal of Clinical Pathologv, 1976, 29, 162. The figure given by the authors for the a priori probability that an individual will have both severe rheumatoid arthritis and ankylosing spondylitis is unreliable and probably too low. It is difficult to know what the second figure "1 in 450 000 to 1 in 1 800 000" is intended to denote. It is presumably meant to imply that the average size of population expected to include nine such patients is 450 000-1 800 000. This figure is probably too high but in any case the total population from which the nine patients were ascertained is undefined and presumably unknown. The probability that the size of this population falls within 95% confidence limits of the above estimate is likely to be quite high. Moreover, three specialised rheumatological centres were involved so that the likelihood of biased ascertainment is considerable.
Among Karch and Lasagna8 emphasise the difficulties in relating specific untoward events to drugs. They categorise adverse drug reactions into definite, probable, conditional, and doubtful subgroups. In the light of the data referred to above one is forced to conclude, using these definitions, that the fatal case of aplastic anaemia described by Drs Toghill and Wilcox was probably if not definitely due to either oxytetracycline or penicillin and that it is doubtful that the hair dye in question was causal. Moreover, since 20O" of women in the United Kingdom are current users of hair colouring products (and many more have used these products at some time) one would expect to find a history of hair colour usage clearly associated with several cases of a disease before drawing any conclusion. Thus I would support Drs Toghill and Wilcox's plea for careful questioning and continuing inquirv in the case of any unusual phenomenon. Metronidazole in treatment of empyema SIR,-Little information is available at present on the penetration of systemic antibiotics into empyemas and we can find no reference on metronidazole in this context. This is perhaps surprising as in one recent study of 83 patients anaerobic bacteria were recovered from 76% of cases (these were the exclusive isolates in 3507)1 and metronidazole has been increasingly recognised for its role in dealing with anaerobic organisms.2 Being a relatively non-toxic antibiotic, well absorbed when given by mouth, we feel its use in empyemas is worthy of consideration. We would like to report our experience with this drug.
A J JOUHAR
An 81-year-old man was admitted with right middle lobe pneumonitis. He subsequently developed a right-sided empyema which was drained with an intercostal tube. An anaerobic bacteroides organism particularly sensitive to metronidazole and also to clindamycin was cultured from the pus. Metronidazole 400 mg and clindamycin 300 mg were given orally six-hourly and the patient made a good recovery. A sample from the intercostal drain taken 31 days after starting this regimen showed a metronidazole concentration-of 24 2 ,ug/ml. The minimum inhibitory and bactericidal concentrations of metronidazole against Bacteroidesfragilis isolated from clinical material, as determined by Whelan and Hale,3 were almost identical in several types of
